Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.

Julie BlancClémence DeschasseLaurent KodjikianCorinne DotAlain-Marie BronCatherine Creuzot-Garcher

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2018)

DEX implants are an effective treatment for BRVO and CRVO-associated ME over 3 years. It is a valid treatment even though complications remain frequent. However, functional efficacy seems to decrease with time and repeated injections.

Keyphrases

diabetic retinopathy
optical coherence tomography
vascular endothelial growth factor
low dose
endothelial cells
combination therapy
risk factors